Target intelligence / Profile preview

ATP-dependent RNA helicase SUPV3L1, mitochondrial (SUPV3L1)

Target
SUPV3L1
Molecular classification
Enzyme, RNA helicase (DExH-box family)
01

Overview

SUPV3L1 encodes an ATP-dependent RNA helicase primarily localized in the mitochondrial matrix, with additional nuclear localization reported. It functions as a major component of the mitochondrial degradosome (mtEXO) complex, unwinding double-stranded RNA, DNA, and RNA/DNA hybrids, mainly in the 3’-to-5’ direction. SUPV3L1 is essential for mitochondrial RNA metabolism, including degradation of non-coding RNAs, processing of tRNA-containing polycistronic transcripts, and regulation of mRNA stability. It contributes to RNA surveillance, preventing the accumulation of deleterious RNA byproducts and maintaining correct transcript and tRNA processing. SUPV3L1 also plays roles in recombination, chromatin maintenance, and protection from apoptosis. Disease mutations in SUPV3L1 disrupt proper mitochondrial RNA processing, resulting in neurodegenerative syndromes, combined oxidative phosphorylation deficiencies, and developmental lethality. SUPV3L1 belongs to the Ski2 family of DExH-box RNA helicases and interacts with polynucleotide phosphorylase (PNPase) in the mitochondrial degradosome. Its critical role in mitochondrial function means therapeutic inhibition could pose significant safety concerns related to mitochondrial disease and neurodegeneration.

Other names
Suv3 like RNA helicaseSUPV3L1SUV3SUV3-like protein 1suppressor of var1 3-like protein 1suppressor of var1, 3-like 1(SUV3)SUPV3L1phSUPV3L1Q8IYB8B1AR60
02

Biological functions

Mitochondrial RNA 3'-end processingMitochondrial RNA surveillanceMitochondrial RNA degradation (catabolic process)Regulation of mRNA stabilityRemoval of aberrant mRNAsRNA/DNA unwindingProcessing of polycistronic mitochondrial transcriptsChromatin maintenanceRegulation of apoptosis
03

Disease associations

Neurodegenerative diseaseCombined oxidative phosphorylation deficiency 13Neuropathy, hereditary motor and sensory, Russe typeOther mitochondrial dysfunction disorders
04

Safety considerations

Therapeutic targeting may risk mitochondrial dysfunction and neurodegenerative syndromesGenetic mutations lead to severe and early-onset disease phenotypes with respiratory chain deficiency and developmental lethality

Beyond the preview

Go deeper on ATP-dependent RNA helicase SUPV3L1, mitochondrial (SUPV3L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent RNA helicase SUPV3L1, mitochondrial (SUPV3L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call